DalsnaFinance

Lexicon earns $10M milestone from Novo Nordisk for obesity drug

Markets Investing.com By Investing.com 24 Aug 2026 12:36 1 min read
Lexicon earns $10M milestone from Novo Nordisk for obesity drug

Covered in this story

Novo Nordisk NOVO-B
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.